VMED — Viromed Medical AG Income Statement
0.000.00%
Last trade - 00:00- €70.88m
- €70.87m
- 14
- 16
- 75
- 23
Annual income statement for Viromed Medical AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 24 W | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.005 | 0.16 | 0.359 | 0.44 |
| Operating Profit | -0.005 | -0.16 | -0.359 | -0.44 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.005 | -0.161 | -0.11 | -0.226 |
| Net Income After Taxes | -0.005 | -0.161 | -0.11 | -0.226 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.005 | -0.161 | -0.11 | -0.226 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.005 | -0.161 | -0.11 | -0.226 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.02 | -0.008 | -0.005 | -0.011 |
| Dividends per Share |